Dimensional Fund Advisors LP Akero Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

$405 Billion
Q4 2024

A detailed history of Dimensional Fund Advisors LP transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 449,110 shares of AKRO stock, worth $20.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

449,110

Previous 7,096 6229.06%

Holding current value

$20.2 Million

Previous $203,000 6054.68%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$26.75 - $35.28 $11.8 Million - $15.6 Million	442,014 Added 6229.06%	449,110 $12.5 Million
Q3 2024 Nov 07, 2024	SELL	$21.45 - $29.34 $237,365 - $324,676	-11,066 Reduced 60.93%	7,096 $203,000
Q2 2024 Aug 09, 2024	SELL	$18.31 - $24.62 $499,386 - $671,485	-27,274 Reduced 60.03%	18,162 $426,000
Q1 2024 May 10, 2024	BUY	$17.76 - $31.18 $434,995 - $763,691	24,493 Added 116.95%	45,436 $1.15 Million
Q4 2023 Feb 07, 2024	SELL	$11.38 - $50.33 $927,208 - $4.1 Million	-81,477 Reduced 79.55%	20,943 $489,000
Q3 2023 Nov 09, 2023	SELL	$41.19 - $52.25 $6.86 Million - $8.7 Million	-166,497 Reduced 61.91%	102,420 $5.18 Million
Q2 2023 Aug 09, 2023	SELL	$36.89 - $56.88 $538,557 - $830,391	-14,599 Reduced 5.15%	268,917 $12.6 Million
Q1 2023 May 12, 2023	SELL	$37.27 - $50.24 $264,244 - $356,201	-7,090 Reduced 2.44%	283,516 $10.8 Million
Q4 2022 Feb 09, 2023	SELL	$33.44 - $54.8 $26,250 - $43,018	-785 Reduced 0.27%	290,606 $15.9 Million
Q3 2022 Nov 10, 2022	SELL	$10.15 - $34.05 $716,559 - $2.4 Million	-70,597 Reduced 19.5%	291,391 $9.92 Million
Q2 2022 Aug 12, 2022	BUY	$8.0 - $15.01 $193,584 - $363,211	24,198 Added 7.16%	361,988 $3.42 Million
Q1 2022 May 13, 2022	BUY	$12.97 - $22.26 $1.11 Million - $1.9 Million	85,525 Added 33.9%	337,790 $4.79 Million
Q4 2021 Feb 09, 2022	BUY	$19.87 - $26.24 $834,917 - $1.1 Million	42,019 Added 19.99%	252,265 $5.34 Million
Q3 2021 Nov 12, 2021	SELL	$18.65 - $25.46 $89,818 - $122,615	-4,816 Reduced 2.24%	210,246 $4.7 Million
Q2 2021 Aug 12, 2021	BUY	$24.81 - $32.35 $4.52 Million - $5.9 Million	182,368 Added 557.8%	215,062 $5.34 Million
Q1 2021 May 14, 2021	SELL	$24.04 - $34.19 $400,025 - $568,921	-16,640 Reduced 33.73%	32,694 $948,000
Q4 2020 Feb 25, 2021	BUY	$25.12 - $29.89 $1.24 Million - $1.47 Million	49,334 New	49,334 $1.27 Million

Others Institutions Holding AKRO

# of Institutions

209

Shares Held

66.9M

Call Options Held

321K

Put Options Held

558K

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $2.09B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Akero Therapeutics, Inc. Transaction History